Outcomes in black and white patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors: Insights from two large cohorts

doi:10.1200/JGO.19.00380

Outcomes in black and white patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors: Insights from two large cohorts

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	293-306
Number of pages	14
Journal	Journal of global oncology
Volume	6
DOIs	https://doi.org/10.1200/JGO.19.00380
Publication status	Published - 2020
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JGO.19.00380

Cite this

@article{d4ded6f8497a44358de71b9994d95f6d,

title = "Outcomes in black and white patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors: Insights from two large cohorts",

note = "Publisher Copyright: {\textcopyright} 2020 by American Society of Clinical Oncology Creative Commons Attribution Non-Commercial No Derivatives 4.0 License",

year = "2020",

doi = "10.1200/JGO.19.00380",

language = "English",

volume = "6",

pages = "293--306",

journal = "Journal of global oncology",

issn = "2378-9506",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Outcomes in black and white patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors

T2 - Insights from two large cohorts

PY - 2020

Y1 - 2020

UR - http://www.scopus.com/inward/record.url?scp=85082929176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082929176&partnerID=8YFLogxK

U2 - 10.1200/JGO.19.00380

DO - 10.1200/JGO.19.00380

M3 - Article

C2 - 32109159

AN - SCOPUS:85082929176

SN - 2378-9506

VL - 6

SP - 293

EP - 306

JO - Journal of global oncology

JF - Journal of global oncology

ER -

Outcomes in black and white patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors: Insights from two large cohorts

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this